Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CIPLA vs ASTRAZENECA PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CIPLA ASTRAZENECA PHARMA CIPLA/
ASTRAZENECA PHARMA
 
P/E (TTM) x 33.8 91.1 37.1% View Chart
P/BV x 4.3 16.5 26.0% View Chart
Dividend Yield % 0.5 0.3 151.9%  

Financials

 CIPLA   ASTRAZENECA PHARMA
EQUITY SHARE DATA
    CIPLA
Mar-22
ASTRAZENECA PHARMA
Mar-22
CIPLA/
ASTRAZENECA PHARMA
5-Yr Chart
Click to enlarge
High Rs1,0834,580 23.6%   
Low Rs8062,529 31.9%   
Sales per share (Unadj.) Rs269.7322.2 83.7%  
Earnings per share (Unadj.) Rs31.724.6 128.7%  
Cash flow per share (Unadj.) Rs44.831.4 142.5%  
Dividends per share (Unadj.) Rs5.0010.00 50.0%  
Avg Dividend yield %0.50.3 188.1%  
Book value per share (Unadj.) Rs257.8203.8 126.5%  
Shares outstanding (eoy) m806.8125.00 3,227.2%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.511.0 31.7%   
Avg P/E ratio x29.8144.3 20.6%  
P/CF ratio (eoy) x21.1113.1 18.7%  
Price / Book Value ratio x3.717.4 21.0%  
Dividend payout %15.840.6 38.8%   
Avg Mkt Cap Rs m762,17788,863 857.7%   
No. of employees `000NANA-   
Total wages/salary Rs m35,2992,302 1,533.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m217,6338,056 2,701.5%  
Other income Rs m3,217148 2,179.7%   
Total revenues Rs m220,8518,204 2,692.1%   
Gross profit Rs m43,298862 5,024.2%  
Depreciation Rs m10,520170 6,206.2%   
Interest Rs m1,06410 11,194.7%   
Profit before tax Rs m34,933830 4,206.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m9,338214 4,355.4%   
Profit after tax Rs m25,595616 4,155.0%  
Gross profit margin %19.910.7 186.0%  
Effective tax rate %26.725.8 103.5%   
Net profit margin %11.87.6 153.8%  
BALANCE SHEET DATA
Current assets Rs m147,1087,653 1,922.2%   
Current liabilities Rs m49,1293,923 1,252.3%   
Net working cap to sales %45.046.3 97.2%  
Current ratio x3.02.0 153.5%  
Inventory Days Days6361 102.5%  
Debtors Days Days639 14.8%  
Net fixed assets Rs m119,4152,120 5,632.8%   
Share capital Rs m1,61450 3,227.2%   
"Free" reserves Rs m206,3645,044 4,090.9%   
Net worth Rs m207,9775,094 4,082.5%   
Long term debt Rs m4,1620-   
Total assets Rs m266,5239,773 2,727.1%  
Interest coverage x33.888.4 38.3%   
Debt to equity ratio x00-  
Sales to assets ratio x0.80.8 99.1%   
Return on assets %10.06.4 156.3%  
Return on equity %12.312.1 101.8%  
Return on capital %17.016.5 102.9%  
Exports to sales %26.20-   
Imports to sales %8.231.7 25.8%   
Exports (fob) Rs m57,094NA-   
Imports (cif) Rs m17,8032,552 697.6%   
Fx inflow Rs m60,180442 13,615.3%   
Fx outflow Rs m17,8032,552 697.6%   
Net fx Rs m42,376-2,110 -2,008.3%   
CASH FLOW
From Operations Rs m33,2591,008 3,299.5%  
From Investments Rs m-18,71947 -39,491.1%  
From Financial Activity Rs m-15,998-95 16,911.1%  
Net Cashflow Rs m-1,323961 -137.7%  

Share Holding

Indian Promoters % 13.5 0.0 -  
Foreign collaborators % 20.1 75.0 26.8%  
Indian inst/Mut Fund % 49.4 3.8 1,295.8%  
FIIs % 27.7 2.5 1,111.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 66.4 25.0 265.6%  
Shareholders   388,864 49,085 792.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CIPLA With:   SUN PHARMA    DR. REDDYS LAB    LUPIN    AUROBINDO PHARMA    ZYDUS LIFESCIENCES    


More on Cipla vs ASTRAZENECA PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Cipla vs ASTRAZENECA PHARMA Share Price Performance

Period Cipla ASTRAZENECA PHARMA S&P BSE HEALTHCARE
1-Day 0.90% -0.13% 0.33%
1-Month -4.37% 7.64% 0.28%
1-Year 22.80% 10.48% -6.55%
3-Year CAGR 31.74% 7.06% 20.31%
5-Year CAGR 12.44% 24.02% 10.96%

* Compound Annual Growth Rate

Here are more details on the Cipla share price and the ASTRAZENECA PHARMA share price.

Moving on to shareholding structures...

The promoters of Cipla hold a 33.6% stake in the company. In case of ASTRAZENECA PHARMA the stake stands at 75.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Cipla and the shareholding pattern of ASTRAZENECA PHARMA.

Finally, a word on dividends...

In the most recent financial year, Cipla paid a dividend of Rs 5.0 per share. This amounted to a Dividend Payout ratio of 15.8%.

ASTRAZENECA PHARMA paid Rs 10.0, and its dividend payout ratio stood at 40.6%.

You may visit here to review the dividend history of Cipla, and the dividend history of ASTRAZENECA PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Ends 21 Points Higher | BHEL, RVNL Surge 10% to Hit 52-Week High | Why PNB Share Price is Rising(Closing)

Indian share markets traded in a rangebound manner throughout today's session to end flat.